These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16707457)

  • 1. Keratoepithelin suppresses the progression of experimental human neuroblastomas.
    Becker J; Erdlenbruch B; Noskova I; Schramm A; Aumailley M; Schorderet DF; Schweigerer L
    Cancer Res; 2006 May; 66(10):5314-21. PubMed ID: 16707457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High activin A-expression in human neuroblastoma: suppression of malignant potential and correlation with favourable clinical outcome.
    Schramm A; von Schuetz V; Christiansen H; Havers W; Papoutsi M; Wilting J; Schweigerer L
    Oncogene; 2005 Jan; 24(4):680-7. PubMed ID: 15580313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurotrophin receptor TrkB cooperates with c-Met in enhancing neuroblastoma invasiveness.
    Hecht M; Schulte JH; Eggert A; Wilting J; Schweigerer L
    Carcinogenesis; 2005 Dec; 26(12):2105-15. PubMed ID: 16051641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A.
    Breit S; Ashman K; Wilting J; Rössler J; Hatzi E; Fotsis T; Schweigerer L
    Cancer Res; 2000 Aug; 60(16):4596-601. PubMed ID: 10969812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion.
    Becker J; Volland S; Noskova I; Schramm A; Schweigerer LL; Wilting J
    Int J Oncol; 2008 Jan; 32(1):235-40. PubMed ID: 18097563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myc down-regulates activin A.
    Breit S; Rössler J; Fotsis T; Schweigerer L
    Biochem Biophys Res Commun; 2000 Aug; 274(2):405-9. PubMed ID: 10913351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
    Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
    Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
    Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
    Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
    Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
    Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
    Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.
    Ikegaki N; Gotoh T; Kung B; Riceberg JS; Kim DY; Zhao H; Rappaport EF; Hicks SL; Seeger RC; Tang XX
    Clin Cancer Res; 2007 Oct; 13(20):6001-9. PubMed ID: 17947461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone.
    van Golen CM; Schwab TS; Kim B; Soules ME; Su Oh S; Fung K; van Golen KL; Feldman EL
    Cancer Res; 2006 Jul; 66(13):6570-8. PubMed ID: 16818629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
    Van Aarsen LA; Leone DR; Ho S; Dolinski BM; McCoon PE; LePage DJ; Kelly R; Heaney G; Rayhorn P; Reid C; Simon KJ; Horan GS; Tao N; Gardner HA; Skelly MM; Gown AM; Thomas GJ; Weinreb PH; Fawell SE; Violette SM
    Cancer Res; 2008 Jan; 68(2):561-70. PubMed ID: 18199553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
    Mangieri D; Nico B; Coluccia AM; Vacca A; Ponzoni M; Ribatti D
    Cancer Lett; 2009 May; 277(2):199-204. PubMed ID: 19150583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
    Tanaka N; Fukuzawa M
    Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.
    Krneta J; Kroll J; Alves F; Prahst C; Sananbenesi F; Dullin C; Kimmina S; Phillips DJ; Augustin HG
    Cancer Res; 2006 Jun; 66(11):5686-95. PubMed ID: 16740706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-spondin plays a critical role in murine neuroblastoma survival by maintaining IL-6 expression.
    Cheng YC; Liang CM; Chen YP; Tsai IH; Kuo CC; Liang SM
    J Neurochem; 2009 Aug; 110(3):947-55. PubMed ID: 19549008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells.
    Schulte JH; Kuhfittig-Kulle S; Klein-Hitpass L; Schramm A; Biard DS; Pfeiffer P; Eggert A
    DNA Repair (Amst); 2008 Oct; 7(10):1757-64. PubMed ID: 18678285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.